Patent details

EP3450553 Title: MRNA THERAPY FOR TREATMENT OF OCULAR DISEASES

Basic Information

Publication number:
EP3450553
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP182013219
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
MRNA THERAPY FOR TREATMENT OF OCULAR DISEASES
French Title of Invention:
THÉRAPIE BASÉE SUR L'ARNM POUR LE TRAITEMENT DES MALADIES OCULAIRES
German Title of Invention:
MRNA-THERAPIE ZUR BEHANDLUNG VON AUGENERKRANKUNGEN
SPC Number:

Dates

Filing date:
19/03/2015
Grant date:
25/12/2019
EP Publication Date:
06/03/2019
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
25/12/2019
EP B1 Publication Date:
25/12/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
19/03/2020
Expiration date:
19/03/2035
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
18/12/2019
 
 

Name:
Translate Bio, Inc.
Address:
29 Hartwell Avenue, Lexington, MA 02421, United States (US)

Inventor

1

Name:
CALIAS, Pericles
Address:
United States (US)

2

Name:
HEARTLEIN, Michael
Address:
United States (US)

3

Name:
DEROSA, Frank
Address:
United States (US)

Priority

Priority Number:
201461969483 P
Priority Date:
24/03/2014
Priority Country:
United States (US)

Classification

IPC classification:
A61K 48/00; C12N 15/02; C12P 21/06;

Publication

European Patent Bulletin

1

Issue number:
201952
Publication date:
25/12/2019
Description:
Grant (B1)

2

Issue number:
202005
Publication date:
29/01/2020
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages